The new 20mg prefilled syringe is a new formulation of Humira that was developed as a treatment for JIA patients with a body weight of between 15kg and 30kg.
In July, 2011, the Japanese Ministry of Health, Labour and Welfare has approved the marketing and manufacturing approval for Humira Prefilled Syringe 20mg/0.4ml.
Abbott Japan is the marketing and manufacturing authorization holder for Humira, while Eisai is responsible for the distribution of the product in Japan.